AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06123182 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Episodic Future Thinking
Description: During the audio recorded guided imagery exercise participants will be asked to think in detail of a future (6 months to a year) where they have made healthy choices regarding physical activity and are physically active.
Study NCT06123182 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Episodic Recent Thinking
Description: During the audio recorded guided imagery exercise participants will be asked to think about a routine weekly activity.
Study NCT06123182 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Episodic Recent Thinking
Description: During the audio recorded guided imagery exercise participants will be asked to think about a routine weekly activity.
Study NCT06123182 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Positive Affective Imagery
Description: During the audio recorded guided imagery exercise participants will be asked to think in detail about the positive outcomes and sensations associated with an exercise bout.
Study NCT05047523 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Depending on the site/region, participants randomized to receive Standard of Care treatment will receive trientine, penicillamine, zinc, or a combination of these medicines, administered according to standard regimens.
Study NCT05651646 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention Arm (STIMFIX)
Description: This is a single-arm prospective multicenter clinical study recruiting 50 subjects who are already undergoing a spinal cord stimulator trial for chronic back pain secondary to failed back surgical syndrome. Each patient who is recruited for spinal cord stimulator trial for their low back pain is informed about the traditional method of managing the leads and the trail lead anchoring system. If the patient agrees for the Stimfix trail lead anchoring clips StimfixTM, then informed consent is taken for anchoring clips usage during the spinal cord stimulator trail.
Study NCT05117970 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AI-enabled ECG-based Screening Tool
Description: Primary care clinicians in the intervention group had access to the report, which displayed whether the AI-ECG result was positive or negative.The system will send a message to corresponding physicians if positive finding.
Study NCT04987281 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT
Study NCT04987281 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indocyanine Green Solution
Description: Given via injection
Study NCT04987281 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Therapeutic Bronchoscopy
Description: Undergo bronchoscopy using Ion robotic bronchoscope
Study NCT05630586 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Semaglutide
Description: Subcutaneous Semaglutide, 0.5 mg weekly for 4 weeks. First dose given at inclusion.
Study NCT05630586 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard care
Description: Treatment according to Danish national clinical guidelines on stroke treatment, including reperfusion therapy if eligible.
Study NCT05630586 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard care
Description: Treatment according to Danish national clinical guidelines on stroke treatment, including reperfusion therapy if eligible.
Study NCT06123182 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Neutral Affective Imagery
Description: During the audio recorded guided imagery exercise participants will be asked to think in detail about the physical sensations associated with an exercise bout.
Study NCT06123182 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Neutral Affective Imagery
Description: During the audio recorded guided imagery exercise participants will be asked to think in detail about the physical sensations associated with an exercise bout.
Study NCT06123182 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HIIT Exercise Intervention
Description: The high intensity interval training (HIIT) will be conducted 2 times per week for 6 weeks. The duration of each individual exercise session will last about 45 minutes. After the 5-minute warm-up at 30% peak workload, HIIT will consist of repeated 1-minute high intensity bursts (on interval) alternated with 1-minute interval recovery (off interval) for 25 minutes. The on interval will begin at 80% of peak watts (range: 75%-85%) followed by the off interval at 10% of peak watts. The session will end with up to 10 minute cool-down at 20% peak workload.
Study NCT06123182 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: HIIT Exercise Intervention
Description: The high intensity interval training (HIIT) will be conducted 2 times per week for 6 weeks. The duration of each individual exercise session will last about 45 minutes. After the 5-minute warm-up at 30% peak workload, HIIT will consist of repeated 1-minute high intensity bursts (on interval) alternated with 1-minute interval recovery (off interval) for 25 minutes. The on interval will begin at 80% of peak watts (range: 75%-85%) followed by the off interval at 10% of peak watts. The session will end with up to 10 minute cool-down at 20% peak workload.
Study NCT06040242 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Participants will perform 3 min of the different activities, followed by a 10-min recovery window.
Study NCT04510636 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab is a intravenously administered humanized monoclonal antibody that blocks the interaction between PD-1 and its ligands, PD-L1 and PD-L2.
Study NCT04510636 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bendamustine Hydrochloride
Description: Bendamustine is a unique alkylating agent with substantial activity in hematologic malignancies.
Study NCT06254196 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Telenursing interventions for monitoring Supportive Care Needs
Description: Use of the Intelligence2health platform, data collection forms on Google Forms, and dedicated telephone line for telenursing remote nursing monitoring interventions.~Based on the data, nurses will be able to implement patient education interventions aimed at preventing and monitoring healthcare support needs related to treatment.
Study NCT06209385 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: YZJ-5053 tablets
Description: YZJ-5053 tablets will be administrated orally QD for 21 days
Study NCT05421650 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: CCRT
Description: 1. Radiation: Extended field-external beam radiation therapy (EF-EBRT) + brachytherapy + lymph node boost.~2. Chemotherapy: Cisplatin 40mg/m2, every week, 4 to 6 cycles.~3. Radiation and chemotherapy are administered concurrently.
Study NCT05421650 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgical debulking of bulky or multiple lymph nodes
Description: 1. Open/minimally invasive method.~2. Surgical debulking of bulky or multiple lymph nodes.~3. Postoperative imaging evaluation to determine whether the lymph node has been successfully removed.
Study NCT05421650 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: CCRT
Description: 1. Radiation: EBRT/EF-EBRT + brachytherapy + lymph node boost.~2. Chemotherapy: Cisplatin 40mg/m2, every week, 4 to 6 cycles.~3. Radiation and chemotherapy are administered concurrently.
Study NCT06095622 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fenugreek Seeds and Indian Rennet
Description: Food herbs like fenugreek Seeds and Indian rennet to formulate rice dish.
Study NCT05958173 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Capsaicin
Description: Oral stimulation with natural TRPV1 agonist
Study NCT05958173 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Piperine
Description: Oral stimulation with natural TRPA1/V1 agonist
Study NCT05958173 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral stimulation with placebo solution
Study NCT05562518 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Estrogen
Description: 1 vaginal ovule daily for three consecutive weeks, followed by 1 vaginal ovule 2 times per week
Study NCT05562518 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dehydroepiandrosterone
Description: 1 vaginal ovule daily
Study NCT05562518 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Estrogen + probiotics
Description: 2 vaginal ovules daily for 5 consecutive days, repeated every 4 weeks
Study NCT05562518 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Moisturizer
Description: 1 vaginal ovule daily for 10 consecutive days, followed by 1 vaginal ovule every three days
Study NCT06189833 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daratumumab
Description: Daratumumab will be administered via a subcutaneous injection (SC)
Study NCT06189833 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bortezomib
Description: Bortezomib will be administered via a subcutaneous injection (SC)
Study NCT06189833 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Lenalidomide will be administered orally
Study NCT06189833 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Dexamethasone will be administered orally
Study NCT06161623 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Laughter Yoga Application
Description: The intervention group took eight sessions of laughter yoga, that is, two sessions per week for 4 weeks. The participants in the intervention group were asked to fill in the data collection tools before the laughter yoga sessions, and after the 4th and 8th yoga sessions.
Study NCT05852886 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Enable Oral Hygiene System (EOHS)
Description: The Enable Oral Hygiene System (EOHS) is a manual toothbrush comprised of a handle and shaft with multiple surfaces of synthetic bristles extending off of the shaft at one end.
Study NCT06280183 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Functional Inspiratory Muscle Training
Description: Inspiratory muscle training is a technique that combines aerobic training with inspiratory muscle training. will be applied simultaneously with aerobic exercise. Participants will work with bicycle ergometry and then continue with IMT in the same session for the first three weeks. The intensity of IMT exercise will be set at 40-60% of MIP.
Study NCT06280183 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Aerobic+Resistive Exercise Traning
Description: Aerobic exercise is planned at 60-85% of the Maximum Heart Rate on a cycle ergometer for 30-40 minutes. Resistive exercise will cover all major muscle groups. The upper body (pectoralis, latissimus dorsi, rotator cuff muscles, deltoid, biceps, triceps), abdominal muscles, and lower extremities (quadriceps, hamstring, gastrosoleus) will be exercised to strengthen. For upper body, abdominal, and lower extremity muscles, 1-3 sets of 10-15 repetitions will be planned as 40-70% of 1 maximum repetition (1RM).
Study NCT05935631 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Salt with folic acid and iodine
Description: Assess serum and RBC folate levels in women at baseline and 1 month after ingesting salt with folic acid
Study NCT05560698 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Motivation-enhancing intervention
Description: The web app is designed as an efficient and easy-to-use app configurable to personal preferences. Each day participants receive a text message on their smartphone with a link for the daily cSMS questionnaire. The questionnaire addresses the same questions as the questionnaire in the standard intervention, but the format is different, and some shortcuts makes it easier to answer. When the questionnaire is answered, the web app gives access to different features. The following features distinct the motivation-enhancing intervention from the standard intervention (1) only complete the entire questionnaire on days with symptoms, (2) integration of grass pollen counts and forecasts, (3) showing personal response rate, (4) access to own data via a graph, (5) advice against grass pollen allergy, (6) status of the study, (7) individually choosing the time of response, (8) option to download an icon for the home screen and (9) contact information. The development is an ongoing iterative process
Study NCT05560698 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard intervention
Description: Each day participants receive a text message on their smartphone with a link for the daily cSMS questionnaire. When the questionnaire is answered, the tab needs to be closed.
Study NCT05230563 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ti-LUNG
Description: Participating clinicians will perform two image interpretations on all cases. One period the clinicians only will perform lung nodule detection on chest CT images, and the other period will perform lung nodule detection on chest CT images with the aid of Taihao lung CT decision support system. In each interpretation, all lung nodule is marked by each radiologist. This test collects chest computerized tomography cases for computer analysis, and evaluates whether the TaiHao lung CT decision support system helps doctors make more accurate diagnoses.
Study NCT05555810 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: clipping or ligation of the cystic duct and the cystic artery in Laparoscopic cholecystectomy
Description: The investigators will make a comparison between clipping and ligation of cystic duct and cystic artery during Laparoscopic cholecystectomy and trying to know advantages and disadvantages of each technique .
Study NCT04720703 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Newsletters
Description: Similar to prior empirical pediatric obesity interventions (Elder et al., 2009), the active attention waitlist control group will receive monthly newsletters that focus on physical activity, healthy eating, and screen time. These newsletters will be based on standard materials from the We Can program of the National Heart, Lung, and Blood Institute (NHLBI).
Study NCT04720703 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family-based Telehealth Intervention
Description: All communications related to the intervention will occur through weekly small group video conferencing calls via Zoom and emails or text messages. The intervention will include diverse topics proven effective in prior interventions (Davis et al., 2019; McLean et al., 2003), including reading food labels, eating out, eating at social gatherings, sticker charts, praising/rewarding healthy choices, healthy foods available at home, portion sizes, healthy/easy/low-cost cooking ideas, goal setting, monitoring screen time, exercise opportunities available in neighborhood, family exercise ideas, and healthy sleep. The research team will also send relevant video/audio clips, brochures, reminders (text messages and emails) every week.
Study NCT05987761 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PRT for Adolescents
Description: Clinician-led 70-minute PRT sessions targeting social skills once per week at Stanford.
Study NCT05152186 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Topical Solution
Description: Topical administration
Study NCT05152186 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Topical Solution
Description: Topical administration
Study NCT05152186 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Topical Foam
Description: Topical administration
Study NCT05152186 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Topical Foam
Description: Topical administration
Study NCT05152186 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Topical
Description: Topical administration
Study NCT05152186 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Topical
Description: Topical administration
Study NCT05557214 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Audit and Feedback Letter
Description: Physicians in the Audit and Feedback Letter Arm will receive an initial letter indicating their high prescriber status with guidance on reducing unnecessary antimicrobial use. They will also receive a follow-up letter at the 6 month mark indicating any change in prescribing habits. There will be a study closure letter mailed at the 12 month mark.
Study NCT04976374 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine and Gabapentin
Description: Administration of intravenous dexmedetomedine for post operative analgesic purposes in combination with gabapentin
Study NCT05596435 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT04976374 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: Intravenous Saline 0.9% for placebo purposes
Study NCT05326516 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Revumenib
Description: Participants will receive revumenib until meeting criteria for discontinuation.
Study NCT05326516 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy Regimen 1
Description: Participants will receive 2 treatment cycles of chemotherapy. During Cycle 1, participants will receive prednisone, vincristine, pegaspargase/calaspargase pegol-mknL, and daunorubicin. During Cycle 2, participants will receive etoposide and cyclophosphamide.
Study NCT05326516 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy Regimen 2
Description: Participants will receive 2 treatment cycles of chemotherapy. During Cycles 1 and 2, participants will receive fludarabine and cytarabine.
Study NCT05773456 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sushi and wakame salad
Description: One serving of mixed sushi and wakame salad
Study NCT05773456 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sushi and wakame salad
Description: One serving of mixed sushi and wakame salad
Study NCT04930380 — intervention group
Intervention type: OTHER
Intervention: phone interview
Description: Cases and controls will receive a phone interview
Study NCT05026190 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: transrectal ultrasound
Description: we perform trus to identify the cause of azospermia and its type either obstructive or not
Study NCT06553859 — intervention group
Intervention type: OTHER
Intervention: No intervention conducts.
Description: The type and method of breast reconstruction with sillicon implants and ADM implanting is now the standard treatment of breast cancer in korea. no any specific intervention has occurred during the surgery.
Study NCT06254820 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: influenza B/Connecticut/1/21 virus part a dose arm 1
Description: Medium dose, expected to be approximately 10\^6 tissue culture infective dose 50% (TCID50)/mL (titer may be adjusted based on stock titer)
Study NCT06254820 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: influenza B/Connecticut/1/21 virus part a dose arm 2
Description: High dose, expected to be approximately 10\^7 TCID50/ mL (titer may be adjusted based on stock titer)
Study NCT06254820 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: influenza B/Connecticut/1/21 virus part b dose 1
Description: Extension of one of the Part A dose arms; which one is to be determined (TBD) depending on outcome of Part A, AND/OR Dose Arm 3
Study NCT05984927 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: NG101 AAV gene therapy
Description: Sub retinal injection of NG101 (a non-replicating adeno-associated virus serotype 8 (AAV8) vector
Study NCT06434168 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yoga intervention
Description: Patients in the yoga group will receive a 60-minute session, twice per week over 12 weeks for a total of 24 sessions. Each yoga session consists of a warm-up, yoga postures standing or seated depending on the capability of the patient, and relaxation.
Study NCT06434168 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Control condition
Description: Patients in the control group will receive care-as-usual from their healthcare providers and will be asked to avoid engaging in yoga during their 3 months in the study.
Study NCT04709549 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Diabetes Prevention Program + Job and Legal Services
Description: Diabetes Prevention Program (DPP) is a one-year lifestyle modification program that helps adults at risk for developing type 2 diabetes gain tools for healthy living.~Job readiness services will be provided by YMCA SF service connectors, trained staff with expertise in employment services who are bi-lingual in English/Spanish and/or Cantonese/English to serve the needs of the community. Service Connectors will assist with providing employment services (e.g job search, potential placement and retention services, relationship development with partners and employers) and job readiness instruction/training.
Study NCT06254820 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: influenza B/Connecticut/1/21 virus part b dose 2
Description: Addition of a 3rd dose, TBD depending on outcome of Part A
Study NCT04709549 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Diabetes Prevention Program
Description: Diabetes Prevention Program (DPP) is a one-year lifestyle modification program that helps adults at risk for developing type 2 diabetes gain tools for healthy living.
Study NCT02179138 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: TFV 1% gel